Acute Pulmonary Actinomycosis Induced by Immunotherapy and Chemotherapy Used for SCLC Treatment: A Case Report and Literature Review
作者全名:"Kuang, Ju; Luo, Zhihai; Zhou, Fu"
作者地址:"[Kuang, Ju; Luo, Zhihai; Zhou, Fu] Chongqing Med Univ, Dept Resp & Crit Care Med, Affiliated Banan Hosp, Chongqing, Peoples R China"
通信作者:"Zhou, F (通讯作者),Chongqing Med Univ, Dept Resp & Crit Care Med, Affiliated Banan Hosp, Chongqing, Peoples R China."
来源:INFECTION AND DRUG RESISTANCE
ESI学科分类:IMMUNOLOGY
WOS号:WOS:001124077600001
JCR分区:Q2
影响因子:2.9
年份:2023
卷号:16
期号:
开始页:7575
结束页:7580
文献类型:Review
关键词:pulmonary actinomycosis; lung cancer; targeted next -generation sequencing; metagenomic next -generation sequencing
摘要:"A 66-year-old male patient diagnosed with small-cell lung cancer received chemotherapy and immunotherapy, resulting in successful tumor control. However, the patient subsequently experienced a fever and rapid progression of the pulmonary cavity. Despite sampling bronchoscopic bronchoalveolar lavage fluid for targeted next-generation sequencing (tNGS), the cause remained unidentified. Adding bronchoalveolar lavage fluid to sense metagenomic next-generation sequencing (mNGS) confirmed the infection caused by actinomycetes. The patient's condition improved after active anti-infection treatment. This case was further analyzed and discussed through a comprehensive literature review, focusing on molecular microbiological diagnosis and treatment processes. The points outlined were as follows: the advancement of molecular microbiology has gradually reduced the challenges associated with diagnosing rare infectious diseases such as pulmonary actinomycosis. Additionally, in immunodeficient individuals, certain infectious diseases with a chronic course may exhibit acute and aggressive characteristics, which is of concern to all colleagues. Currently, tNGS and mNGS are widely employed in clinical settings as practical tools for diagnosing infectious diseases. Notably, these two methods are not substitutes for each other but complement each other."
基金机构:
基金资助正文: